KOLON LIFE SCIENCE (102940) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, KOLON LIFE SCIENCE (102940) reported revenue of 209.0 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
2025209.0 billion KRW17.6 billion KRW25.0 billion KRW[source]
2024161.4 billion KRW-22.1 billion KRW-93.1 billion KRW[source]
2023124.6 billion KRW-24.1 billion KRW-30.7 billion KRW[source]
2022192.4 billion KRW1.6 billion KRW2.1 billion KRW[source]
2021165.5 billion KRW3.9 billion KRW-1.4 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025906.4 billion KRW323.7 billion KRW582.7 billion KRW[source]
2024413.2 billion KRW264.7 billion KRW148.5 billion KRW[source]
2023304.2 billion KRW166.5 billion KRW137.7 billion KRW[source]
2022305.1 billion KRW137.3 billion KRW167.8 billion KRW[source]
2021220.3 billion KRW121.0 billion KRW99.3 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice